[Genetic and teratogenic risks in substance-dependent patients].
Passarge
E
E
Institut für Humangenetik, Universitätsklinikum, Essen.
Hauss-Albert
H
H
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D002186:Cannabinoids / Q000009:adverse effects; D002869:Chromosome Aberrations / Q000139:chemically induced*; D025063:Chromosome Disorders; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D009294:Narcotics / Q000009:adverse effects; D011247:Pregnancy; D011619:Psychotropic Drugs / Q000009:adverse effects*; D012307:Risk Factors; D019966:Substance-Related Disorders / Q000150:complications*
D002186:Cannabinoids; D009294:Narcotics; D011619:Psychotropic Drugs; D008238:Lysergic Acid Diethylamide
Zur Frage genetischer und teratogener Risiken drogenabhängiger Patienten.